Sources | Names Used |
---|---|
GDSC1000 | KIN001-270 |
PharmacoGx | KIN001-270 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CNTLN | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | EXOC3 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | SLC12A4 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | CFI | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | NHLRC3 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | SLC9B2 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | SF1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | ORC6 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | ACTA2 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | FCRL5 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |